Symposium 4: Vitamins, infectious and chronic disease during adulthood and agingC1 metabolism and CVD outcomes in older adults

Proceedings of the Nutrition Society

Volumn 71, Issue 2, 2012, Pages 213-221

  McNulty, Helene ^a   Strain, J J ^a   Pentieva, Kristina ^a   Ward, Mary ^a  

^a UNIVERSITY OF ULSTER   (United Kingdom)

Author keywords

Cardiovascular risk; Folate and folic acid; Homocysteine; MTHFR C677T polymorphism; Riboflavin

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; RIBOFLAVIN; VITAMIN B GROUP; CARBON; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); VITAMIN B COMPLEX;

CARDIOVASCULAR DISEASE; CHRONIC DISEASE; CONFERENCE PAPER; CONGENITAL HEART DISEASE; GENETIC VARIABILITY; HEART DISEASE; HUMAN; HYPERTENSION; INFECTION; RISK FACTOR; STROKE; BLOOD; BLOOD PRESSURE; DRUG EFFECT; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; METABOLISM; REVIEW;

BLOOD PRESSURE; CARBON; CARDIOVASCULAR DISEASES; FOLIC ACID; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEART DISEASES; HOMOCYSTEINE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); POLYMORPHISM, GENETIC; RIBOFLAVIN; STROKE; VITAMIN B COMPLEX;

EID: 84860872362     PISSN: 00296651     EISSN: 14752719     Source Type: Journal    
DOI: 10.1017/S0029665111003387     Document Type: Conference Paper

References (50)

1. Homocysteine Lowering Trialists? Collaboration (2005) Dose-dependent effects of folic acid on blood concentrations of homocysteine: A meta-analysis of the randomized trials. Am J Clin Nutr 82, 806-812.
2. Eussen SJ, de Groot LC, Clarke R et al. (2005) Oral cyanocobalamin supplementation in older people with vitamin B12 deficiency: A dose-finding trial. Arch Intern Med 165, 1167-1172.
3. McKinley MC, McNulty H, McPartlin J et al. (2001) Low-dose vitamin B-6 effectively lowers fasting plasma homocysteine in healthy elderly persons who are folate and riboflavin replete. Am J Clin Nutr 73, 759-764.
4. McNulty H, Dowey le RC, Strain JJ et al. (2006) Riboflavin lowers homocysteine in individuals homozygous for the MTHFR 677C-
5. Strain JJ, Dowey L, Ward M et al. (2004) B-vitamins, homocysteine metabolism and CVD. Proc Nutr Soc 63, 597-603.
6. The Homocysteine Studies Collaboration (2002) Homocysteine and risk of ischemic heart disease and stroke. JAMA 288, 2015-2022.
7. Wald DS, Law M & Morris JK (2002) Homocysteine and cardiovascular disease: Evidence on causality from a metaanalysis. BMJ 325, 1202-1208.
8. Yang Q, Botto LD, Erickson JD et al. (2006) Improvement in stroke mortality in Canada and the United States, 1990 to 2002. Circulation 113, 1335-1343.
9. Toole JF, Malinow MR, Chambless LE et al. (2004) Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: The Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA 291, 565-575.
10. Lonn E, Yusuf S, Arnold MJ et al. (2006) Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med 354, 1567-1577.
11. Bønaa KH, Njølstad I, Ueland PM et al. (2006) Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 354, 1578-1588.
12. Ebbing M, Bleie Ø, Ueland PM et al. (2008) Mortality and cardiovascular events in patients treated with homocysteinelowering B vitamins after coronary angiography: A randomized controlled trial. JAMA 300, 795-804.
13. Albert CM, Cook NR, Gaziano JM et al. (2008) Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease. A randomized trial. JAMA 299, 2027-2036.
14. Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH) Collaborative Group (2010) Effects of homocysteine- lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors. JAMA 303, 2486-2494.
15. VITATOPS Trial Study Group (2010) B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: A randomised, double-blind, parallel, placebo-controlled trial. Lancet Neurol 9, 855-865.
16. B-Vitamin Treatment Trialists? Collaboration (2006) Homocysteine-lowering trials for prevention of cardiovascular events: A review of the design and power of the large randomized trials. Am Heart J 151, 282-287.
17. Saposnik G, Ray JG, Sheridan P et al. (2009) Homcysteinelowering therapy and stroke risk, severity, and disability: Additional findings from the HOPE 2 trial. Stroke 40, 1365-1372.
18. Wang X, Qin X, Demirtas H et al. (2007) Efficacy of folic acid supplementation in stroke prevention: A meta-analysis. Lancet 369, 1876-1882.
19. Lee M, Hong KS, Chang SC et al. (2010) Efficacy of homocysteine-lowering therapy with folic acid in stroke prevention: A meta-analysis. Stroke 41, 1205-1212.
20. Frosst P, Blom HJ, Milos R et al. (1995) A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nat Genet 10, 111-113.
21. Jacques PF, Bostom AG, Williams RR et al. (1996) Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 93, 7-9.
22. Wilcken B, Bamforth F, Li Z et al. (2003) Geographical and ethnic variation of the 677C!T allele of 5, 10 methylenetetrahydrofolate reductase (MTHFR): Findings from over 7000 newborns from 16 areas world wide. J Med Genet 40, 619-625.
23. Klerk M, Verhoef P, Clarke R et al. (2002) MTHFR C677T polymorphism and risk of coronary heart disease: A metaanalysis. JAMA 288, 2023-2031.
24. Lewis SJ, Ebrahim S & Davey-Smith G (2005) Meta-analysis of the MTHFR 677C!T polymorphism and coronary heart disease: Does totality of evidence support causal role for homocysteine and preventative potential of folate. Br Med J 331, 1053-1059.
25. Holmes MV, Newcombe P, Hubacek JA et al. (2011) Effect modification by population dietary folate on the association between MTHFR genotype, homocysteine, and stroke risk: A meta-analysis of genetic studies and randomised trials. Lancet 378, 584-594.
26. Wang W, Lee ET, Fabsitz RR et al. (2006) A longitudinal study of hypertension risk factors and their relation to cardiovascular disease: The Strong Heart Study. Hypertension 47, 403-409.
27. Staessen JA, Wang JG & Thijs L (2001) Cardiovascular protection and BP reduction: A meta-analysis. Lancet 358, 1305-1315.
28. Wilson CP, McNulty H, Scott JM et al. (2010) The MTHFR C677T polymorphism, B-vitamins and blood pressure. Proc Nutr Soc 69, 156-165.
29. Horigan G, McNulty H, Ward M et al. (2010) Riboflavin lowers blood pressure in cardiovascular disease patients homozygous for the C677T polymorphism in MTHFR. J Hypertens 28, 478-486.
30. Yamada K, Chen Z, Rozen R et al. (2001) Effects of common polymorphisms on the properties of recombinant human methylenetetrahydrofolate reductase. Proc Natl Acad Sci USA 98, 14853-14858.
31. Antoniades C, Shirodaria C, Leeson P et al. (2009) MTHFR 677 C>T Polymorphism reveals functional importance for 5-methyltetrahydrofolate, not homocysteine, in regulation of vascular redox state and endothelial function in human atherosclerosis. Circulation 119, 2507-2515.
32. McNulty H & Scott JM (2008) Intake and status of folate and related B-vitamins: Considerations and challenges in achieving optimal status. Br J Nutr 99, S48-S54.
33. Hoey L, McNulty H, Askin N et al. (2007) Impact of a voluntary food fortification policy on folate, related B-vitamin status and homocysteine in healthy adults. Am J Clin Nutr 86, 1405-1413.
34. McNulty B, Pentieva K, Marshall B et al. (2011) Women?s compliance with current folic acid recommendations and achievement of optimal vitamin status for preventing neural tube defects. Hum Reprod 26, 1530-1536.
35. Reynolds E (2006) Vitamin B12, folic acid, and the nervous system. Lancet Neurol 5, 949-960.
36. Morris MS, Jacques PF, Rosenberg IH et al. (2007) Folate and vitamin B12 status in relation to anemia, macrocytosis, and cognitive impairment in older Americans in the age of folic acid fortification. Am J Clin Nutr 85, 193-200.
37. Kim Y-I (1999) Folate and carcinogenesis: Evidence, mechanisms, and implications. J Nutr Biochem 10, 66-88.
38. Ericson U, Sonestedt E, Gullberg B et al. (2007) High folate intake is associated with lower breast cancer incidence in postmenopausal women in the Malmo Diet and Cancer cohort. Am J Clin Nutr 86, 434-443.
39. Gibson TM, Weinstein SJ, Pfeiffer RM et al. (2011) Pre- and postfortification intake of folate and risk of colorectal cancer in a large prospective cohort study in the United States. Am J Clin Nutr 94, 1053-1062.
40. Cole BF, Baron JA, Sandler RS et al. (2007) Folic acid for the prevention of colorectal adenomas: A randomized clinical trial. JAMA 297, 2351-2359.
41. Figueiredo JC, Grau MV, Haile RW et al. (2009) Folic acid and risk of prostate cancer: Results from a randomized clinical trial. J Natl Cancer Inst 101, 432-435.
42. Ebbing M, Bønaa KH, Nygård O et al. (2009) Cancer incidence and mortality after treatment with folic acid and vitamin B12. JAMA 302, 2119-2126.
43. Mason JB (2011) Folate consumption and cancer risk: A confirmation and some reassurance, but we?re not out of the woods quite yet. Am J Clin Nutr 94, 965-966.
44. Tighe P, Ward M, McNulty H et al. (2011) A dose-finding trial of the effect of long-term folic acid intervention: Implications for food fortification policy. Am J Clin Nutr 93, 11-18.
45. Malinow MR, Bostom AG & Krauss RM (1999) Homocyst( e)ine, diet, and cardiovascular diseases: A statement for healthcare professionals from the Nutrition Committee, American Heart Association. Circulation 99, 178-182.
46. Hoey L, Strain JJ & McNulty H (2009) Studies of biomarker responses to intervention with vitamin B-12: A systematic review of randomized controlled trials. Am J Clin Nutr 89, Suppl., 1981S-1996S.
47. Clarke R, Refsum H, Birks J et al. (2003) Screening for vitamin B-12 and folate deficiency in older persons. Am J Clin Nutr 77, 1241-1247.
48. Carmel R (1997) Cobalamin, the stomach, and aging. Am J Clin Nutr 66, 750-759.
49. Institute of Medicine, Panel on Folate, Other B Vitamins, and Choline (1998) Dietary Reference Intake; Thiamine, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. Washington, DC: National Academy Press.
50. Ruston D, Hoare J, Henderson L et al. (2004) The National Diet and Nutrition Survey: Adults Aged 19 to 64 Years. Vol. 4: Nutritional Status (Anthropometry and Blood Analytes), Blood Pressure and Physical Activity. London: The Stationery Office.